Apellis Pharmaceuticals IncNASDAQ:APLS
- LAST PRICE40.8350
- TODAY'S CHANGE (%)0.4650 (1.1518%)
- Bid / Lots40.7700/ 1
- Ask / Lots40.8600/ 4
- Open / Previous Close40.3000 / 40.3700
- Day Range
- 52 Week Range
- Volume434,570
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | APLS |
|---|---|---|
| 09:32 ET | 10941 | 40.57 |
| 09:34 ET | 1150 | 40.34 |
| 09:36 ET | 2500 | 40.6 |
| 09:38 ET | 3351 | 40.83 |
| 09:39 ET | 2984 | 40.67 |
| 09:41 ET | 1000 | 40.815 |
| 09:43 ET | 500 | 41.015 |
| 09:45 ET | 2685 | 40.97 |
| 09:48 ET | 1200 | 40.88 |
| 09:50 ET | 1000 | 40.81 |
| 09:52 ET | 1293 | 40.93 |
| 09:54 ET | 400 | 40.915 |
| 09:56 ET | 700 | 40.99 |
| 09:57 ET | 800 | 41.045 |
| 09:59 ET | 100 | 41.135 |
| 10:01 ET | 14869 | 41.17 |
| 10:03 ET | 828 | 41.21 |
| 10:06 ET | 3174 | 41.32 |
| 10:08 ET | 14269 | 40.99 |
| 10:10 ET | 898 | 41.11 |
| 10:12 ET | 11290 | 41.07 |
| 10:14 ET | 2904 | 40.9 |
| 10:15 ET | 2545 | 40.93 |
| 10:17 ET | 9281 | 40.96 |
| 10:19 ET | 17512 | 40.84 |
| 10:21 ET | 2670 | 40.83 |
| 10:24 ET | 25790 | 41.055 |
| 10:26 ET | 26209 | 40.9 |
| 10:30 ET | 17652 | 40.9 |
| 10:32 ET | 21328 | 40.9 |
| 10:33 ET | 1948 | 41.2 |
| 10:35 ET | 1100 | 41.2 |
| 10:37 ET | 3593 | 41.365 |
| 10:39 ET | 1647 | 41.07 |
| 10:42 ET | 400 | 41.055 |
| 10:44 ET | 2900 | 41.06 |
| 10:46 ET | 487 | 41.09 |
| 10:48 ET | 325 | 41.105 |
| 10:50 ET | 793 | 41.18 |
| 10:51 ET | 300 | 41.22 |
| 10:53 ET | 1600 | 41.21 |
| 10:55 ET | 897 | 41.17 |
| 10:57 ET | 1118 | 41.26 |
| 11:00 ET | 1060 | 41.39 |
| 11:02 ET | 531 | 41.24 |
| 11:04 ET | 668 | 40.98 |
| 11:06 ET | 400 | 40.97 |
| 11:08 ET | 1156 | 41.04 |
| 11:09 ET | 800 | 41.025 |
| 11:11 ET | 765 | 41.17 |
| 11:13 ET | 600 | 41.06 |
| 11:15 ET | 300 | 41.085 |
| 11:18 ET | 531 | 41.09 |
| 11:20 ET | 430 | 41.05 |
| 11:22 ET | 1294 | 41.075 |
| 11:24 ET | 300 | 41.11 |
| 11:27 ET | 292 | 41.205 |
| 11:29 ET | 1000 | 41.2525 |
| 11:33 ET | 919 | 41.2 |
| 11:36 ET | 1343 | 41.05 |
| 11:40 ET | 400 | 40.96 |
| 11:42 ET | 577 | 40.945 |
| 11:44 ET | 685 | 40.83 |
| 11:45 ET | 100 | 40.885 |
| 11:47 ET | 1975 | 40.94 |
| 11:49 ET | 200 | 40.995 |
| 11:51 ET | 200 | 40.9401 |
| 11:54 ET | 500 | 41 |
| 11:56 ET | 1000 | 41.07 |
| 11:58 ET | 500 | 41.11 |
| 12:00 ET | 1742 | 41.11 |
| 12:02 ET | 809 | 41.16 |
| 12:03 ET | 200 | 41.125 |
| 12:05 ET | 2164 | 41.025 |
| 12:07 ET | 300 | 41.015 |
| 12:09 ET | 2609 | 41.02 |
| 12:12 ET | 400 | 41.085 |
| 12:14 ET | 300 | 41.02 |
| 12:16 ET | 500 | 41.08 |
| 12:18 ET | 658 | 41.075 |
| 12:20 ET | 300 | 41.065 |
| 12:21 ET | 300 | 41.095 |
| 12:23 ET | 2184 | 41.005 |
| 12:25 ET | 4585 | 40.85 |
| 12:27 ET | 435 | 40.885 |
| 12:30 ET | 1436 | 40.905 |
| 12:32 ET | 200 | 40.895 |
| 12:34 ET | 300 | 40.895 |
| 12:36 ET | 618 | 40.86 |
| 12:38 ET | 1000 | 40.91 |
| 12:39 ET | 1219 | 40.9251 |
| 12:41 ET | 1400 | 40.955 |
| 12:43 ET | 200 | 40.98 |
| 12:45 ET | 512 | 40.98 |
| 12:48 ET | 400 | 40.945 |
| 12:50 ET | 4769 | 40.84 |
| 12:52 ET | 300 | 40.855 |
| 12:54 ET | 200 | 40.855 |
| 12:56 ET | 1584 | 40.9 |
| 12:57 ET | 2631 | 40.945 |
| 01:01 ET | 200 | 41.01 |
| 01:03 ET | 2495 | 40.835 |
| 01:06 ET | 408 | 40.86 |
| 01:08 ET | 900 | 40.87 |
| 01:10 ET | 400 | 40.87 |
| 01:12 ET | 1798 | 40.94 |
| 01:14 ET | 900 | 40.92 |
| 01:15 ET | 1115 | 40.97 |
| 01:17 ET | 400 | 40.96 |
| 01:19 ET | 400 | 40.93 |
| 01:21 ET | 961 | 40.89 |
| 01:26 ET | 1582 | 40.77 |
| 01:28 ET | 1505 | 40.79 |
| 01:30 ET | 622 | 40.75 |
| 01:32 ET | 404 | 40.78 |
| 01:33 ET | 2800 | 40.73 |
| 01:35 ET | 872 | 40.725 |
| 01:37 ET | 300 | 40.67 |
| 01:39 ET | 2213 | 40.79 |
| 01:42 ET | 401 | 40.825 |
| 01:44 ET | 200 | 40.825 |
| 01:46 ET | 1559 | 40.85 |
| 01:48 ET | 900 | 40.93 |
| 01:50 ET | 600 | 40.96 |
| 01:51 ET | 860 | 40.955 |
| 01:53 ET | 608 | 40.9 |
| 01:55 ET | 200 | 40.91 |
| 01:57 ET | 1053 | 40.95 |
| 02:00 ET | 508 | 40.935 |
| 02:02 ET | 784 | 40.945 |
| 02:04 ET | 1800 | 40.96 |
| 02:06 ET | 200 | 40.945 |
| 02:08 ET | 1781 | 40.88 |
| 02:09 ET | 500 | 40.885 |
| 02:11 ET | 400 | 40.835 |
Today
Jun 5, 2024
Apellis Pharmaceuticals to Host a Fireside Chat at the Goldman Sachs 45th Annual Global Healthcare Conference, from 7:00AM ET on Wednesday Jun 05, 2024 by Dow Jones
7:00AM ET on Wednesday Jun 05, 2024 by Dow Jones
May 31, 2024
DJ Apellis Pharmaceuticals Initiated at Neutral by Piper Sandler, from 6:05AM ET on Friday May 31, 2024 by Dow Jones
6:05AM ET on Friday May 31, 2024 by Dow Jones
May 28, 2024
DJ Apellis Pharmaceuticals Price Target Maintained With a $92.00/Share by HC Wainwright & Co., from 6:41AM ET on Tuesday May 28, 2024 by Dow Jones
6:41AM ET on Tuesday May 28, 2024 by Dow Jones
May 24, 2024
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Apellis Pharmaceuticals Inc | 5.0B | -11.8x | --- |
CRISPR Therapeutics AG | 5.1B | -21.8x | --- |
Ultragenyx Pharmaceutical Inc | 3.4B | -5.2x | --- |
Amicus Therapeutics Inc | 3.1B | -20.2x | --- |
Guardant Health Inc | 3.8B | -7.6x | --- |
Axsome Therapeutics Inc | 3.5B | -11.2x | --- |
Company Information
Apellis Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system. SYFOVRE (pegcetacoplan injection) is the Company’s approved treatment for geographic atrophy secondary to age-related macular degeneration (GA). Its EMPAVELI (pegcetacoplan), is for the treatment of paroxysmal nocturnal hemoglobinuria (PNH). Its Aspaveli (pegcetacoplan) for the treatment of adults with PNH who are anemic after treatment with a C5 inhibitor for at least three months. Systemic pegcetacoplan has also been approved for the treatment of PNH in Japan, Saudi Arabia, Australia, the United Kingdom and other jurisdictions. Systemic pegcetacoplan is marketed under the trade name EMPAVELI in the United States, Saudi Arabia and Australia and Aspaveli in the European Union, Japan and United Kingdom.
Contact Information
- Headquarters
- 100 Fifth AvenueWALTHAM, MA, United States 02451
- Phone
- 617-977-5700
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Gerald Chan
- President, Chief Executive Officer, Co-Founder, Director
- Cedric Francois
- Co-Founder, Chief Scientific Officer
- Pascal Deschatelets
- Chief Financial Officer, Treasurer
- Timothy Sullivan
- Chief Technical Operations Officer
- Nur Nicholson
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $5.0B |
|---|---|
Revenue (TTM) | $524.1M |
Shares Outstanding | 121.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.88 |
EPS | $-3.46 |
Book Value | $1.63 |
P/E Ratio | -11.8x |
Price/Sales (TTM) | 9.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -77.11% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
